QuidelOrtho Corporation
QDELNASDAQHealthcare● Active
$14.59
+$0.26(+1.81%)
Market Cap$994906530
P/E Ratio—
52W High$35.58
52W Low$9.92
QuidelOrtho Corporation (QDEL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
QDEL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$0.04
Est. $0.37 · -110.8%
Revenue
$0.62B
Est. $0.67B · -6.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
QDEL reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | -$0.03 | — | — | — | $0.62B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.37 | -$0.04 | -110.8% | $0.62B | $0.67B | -6.8% |
| ▲ Q1 FY2026 | Feb 11, 2026 | $0.43 | $0.46 | +7.0% | $0.72B | $0.70B | +3.3% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.51 | $0.80 | +56.9% | $0.70B | $0.70B | -0.1% |
| ▼ Q3 FY2025 | Aug 5, 2025 | $0.56 | $0.12 | -78.6% | $0.62B | $0.68B | -9.1% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.58 | $0.74 | +27.6% | $0.69B | $0.69B | +0.1% |
| ▲ Q1 FY2025 | Feb 12, 2025 | $0.55 | $0.63 | +14.6% | $0.71B | $0.72B | -1.4% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.31 | $0.85 | +174.2% | $0.73B | $0.70B | +4.2% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
-$0.04
EPS Est.
$0.37
EPS Surpr.
-110.8%
Revenue
$0.62B
Q1 FY2026
Feb 11, 2026Beat
EPS Actual
$0.46
EPS Est.
$0.43
EPS Surpr.
+7.0%
Revenue
$0.72B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.80
EPS Est.
$0.51
EPS Surpr.
+56.9%
Revenue
$0.70B
Q3 FY2025
Aug 5, 2025Miss
EPS Actual
$0.12
EPS Est.
$0.56
EPS Surpr.
-78.6%
Revenue
$0.62B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.74
EPS Est.
$0.58
EPS Surpr.
+27.6%
Revenue
$0.69B
Q1 FY2025
Feb 12, 2025Beat
EPS Actual
$0.63
EPS Est.
$0.55
EPS Surpr.
+14.6%
Revenue
$0.71B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.85
EPS Est.
$0.31
EPS Surpr.
+174.2%
Revenue
$0.73B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.94 | $0.95 | $0.96 | 2 |
| Q3 FY2028 | $0.86 | $0.87 | $0.88 | 2 |
| Q2 FY2028 | $0.67 | $0.68 | $0.68 | 2 |
| Q1 FY2028 | $0.66 | $0.67 | $0.67 | 2 |
| Q4 FY2027 | $1.13 | $1.15 | $1.16 | 1 |
| Q3 FY2027 | $0.91 | $0.92 | $0.93 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.8B | $0.8B | $0.8B | 1 |
| Q3 FY2028 | $0.7B | $0.8B | $0.8B | 1 |
| Q2 FY2028 | $0.7B | $0.7B | $0.7B | 1 |
| Q1 FY2028 | $0.7B | $0.7B | $0.7B | 1 |
| Q4 FY2027 | $0.8B | $0.8B | $0.8B | 1 |
| Q3 FY2027 | $0.7B | $0.7B | $0.7B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -110.8% | $12.42 | $11.66 | -6.12% |
| ▲ Q1 FY2026 | Feb 11, 2026 | +7.0% | $29.21 | $28.80 | -1.40% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +56.9% | $27.13 | $27.37 | +0.88% |
| ▼ Q3 FY2025 | Aug 5, 2025 | -78.6% | $24.11 | $23.68 | -1.78% |
| ▲ Q2 FY2025 | May 7, 2025 | +27.6% | $25.94 | $25.85 | -0.35% |
| ▲ Q1 FY2025 | Feb 12, 2025 | +14.6% | $41.47 | $39.94 | -3.69% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +174.2% | $39.96 | $38.85 | -2.78% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +66.7% | $39.78 | $39.29 | -1.23% |
Q2 FY2026-6.12%
Report Date
May 5, 2026
EPS Beat/Miss
-110.8%
Price Before
$12.42
Price After
$11.66
Q1 FY2026-1.40%
Report Date
Feb 11, 2026
EPS Beat/Miss
+7.0%
Price Before
$29.21
Price After
$28.80
Q4 FY2025+0.88%
Report Date
Nov 5, 2025
EPS Beat/Miss
+56.9%
Price Before
$27.13
Price After
$27.37
Q3 FY2025-1.78%
Report Date
Aug 5, 2025
EPS Beat/Miss
-78.6%
Price Before
$24.11
Price After
$23.68
Q2 FY2025-0.35%
Report Date
May 7, 2025
EPS Beat/Miss
+27.6%
Price Before
$25.94
Price After
$25.85
Q1 FY2025-3.69%
Report Date
Feb 12, 2025
EPS Beat/Miss
+14.6%
Price Before
$41.47
Price After
$39.94
Q4 FY2024-2.78%
Report Date
Nov 7, 2024
EPS Beat/Miss
+174.2%
Price Before
$39.96
Price After
$38.85
Q3 FY2024-1.23%
Report Date
Jul 31, 2024
EPS Beat/Miss
+66.7%
Price Before
$39.78
Price After
$39.29
Avg Beat Reaction-1.43%
Avg Miss Reaction-3.95%
Beat Rate6 / 8 quarters
Largest Move-6.12% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: QDEL ends December
QuidelOrtho Corporation (QDEL) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-0.04 — missing the analyst consensus of $0.37 by -110.8%. The next QDEL earnings date is expected around September 1, 2026.
Each quarter, investors track QDEL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. QDEL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
QDEL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
QDEL earnings · 5 questionsQuidelOrtho Corporation's next earnings report is expected around September 1, 2026. QDEL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; QDEL historically reports after market close (AMC).
QDEL earnings datewhen is QDEL earningsQDEL next earnings datewhen does QDEL report earningsQDEL earnings calendar
▸ Source: FMP · QuidelOrtho Corporation SEC filings · US GAAP · QuidelOrtho Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026